Join to View Full Profile
OR Hlth Sci Univ Sch of MedPortland, OR 97086
Dr. Javidi-Sharifi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Oregon Health & Science University (OHSU Health)Residency, Internal Medicine, 2018 - 2021
Oregon Health and Science University School of MedicineClass of 2018, MD, PhD
Certifications & Licensure
OR State Medical License 2019 - Present
MA State Medical License 2020 - 2025
American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- A phase 1 study of the CDK9 inhibitor voruciclib in relapsed/refractory acute myeloid leukemia and B-cell malignancies.Matthew S Davids, Danielle M Brander, Yesid Alvarado-Valero, Catherine S Diefenbach, Daniel N Egan
Blood Advances. 2025-02-25 - 17 citationsLMTK3 Is Essential for Oncogenic KIT Expression in KIT-mutant GIST and MelanomaLillian R. Klug, Amber E Bannon, Nathalie Javidi-Sharifi, Ajia Town, William H. Fleming
Oncogene. 2019-02-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
